• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Blueprint Medicines Corporation - Common Stock (NQ:BPMC)

129.46 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 129.46
Bid (Size) 129.45 (10)
Ask (Size) 129.73 (55)
Prev. Close 129.46
Today's Range 129.46 - 129.46
52wk Range 73.04 - 129.65
Shares Outstanding 63,525,838
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal as VYKAT™ XR Sales Soar
April 06, 2026
Shares of Soleno Therapeutics (NASDAQ: SLNO) surged more than 32% in early trading on Monday, April 6, 2026, following the blockbuster announcement that Neurocrine Biosciences (NASDAQ: NBIX) has... 
Via MarketMinute
Topics Intellectual Property
News headline image
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
November 14, 2025
The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+61.4%
+61.4%

More News

Read More
News headline image
Cogent Biosciences Soars to 52-Week High on "Breakthrough" Systemic Mastocytosis Trial Results
October 13, 2025
Via MarketMinute
Topics Economy Supply Chain
News headline image
Shareholder Alert: The Ademi Firm Continues to Investigate the Blueprint Medicines Corporation Transaction
September 15, 2025
From Ademi & Fruchter LLP
Via Business Wire
News headline image
Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction
August 27, 2025
From Ademi & Fruchter LLP
Via Business Wire
News headline image
Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy ↗
July 22, 2025
Via Benzinga
News headline image
What's Driving the Market Sentiment Around Blueprint Medicines? ↗
July 14, 2025
Via Benzinga
News headline image
Cogent's Chronic Immune Disorder Drug Has Strong Potential To Become A Blockbuster: Analyst ↗
July 08, 2025
Via Benzinga
News headline image
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
June 20, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
June 17, 2025
Via Benzinga
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, SVT, SSBK on Behalf of Shareholders
June 15, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Unusual volume stocks are being observed in Monday's session. ↗
June 09, 2025
Via Chartmill
News headline image
Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio? ↗
June 08, 2025
Via Benzinga
News headline image
Deal Dispatch: TV Stations For Sale, This Buyer Wants Seconds On Pasta ↗
June 06, 2025
Via Benzinga
Topics Bankruptcy
News headline image
This Snowflake Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗
June 04, 2025
Via Benzinga
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, STR, BPMC, STRM on Behalf of Shareholders
June 04, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
June 03, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
This ASML Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
June 03, 2025
Via Benzinga
News headline image
This Salesforce Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
June 03, 2025
Via Benzinga
News headline image
Market Monitor News June 03 (Cleveland-Cliffs, Blueprint Medicines UP - First Solar DOWN) ↗
June 03, 2025
Via Chartmill
News headline image
Blueprint Medicines Stock Lands Several Downgrades After Sanofi’s Buyout Deal, But Retail Bulls Keep The Faith ↗
June 02, 2025
Via Stocktwits
Topics Government
News headline image
Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday ↗
June 02, 2025
Via Benzinga
News headline image
Which stocks are gapping on Monday? ↗
June 02, 2025
Via Chartmill
News headline image
Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Monday ↗
June 02, 2025
Via Benzinga
News headline image
This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗
June 02, 2025
Via Benzinga

Frequently Asked Questions

Is Blueprint Medicines Corporation - Common Stock publicly traded?
Yes, Blueprint Medicines Corporation - Common Stock is publicly traded.
What exchange does Blueprint Medicines Corporation - Common Stock trade on?
Blueprint Medicines Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Blueprint Medicines Corporation - Common Stock?
The ticker symbol for Blueprint Medicines Corporation - Common Stock is BPMC on the Nasdaq Stock Market
What is the current price of Blueprint Medicines Corporation - Common Stock?
The current price of Blueprint Medicines Corporation - Common Stock is 129.46
When was Blueprint Medicines Corporation - Common Stock last traded?
The last trade of Blueprint Medicines Corporation - Common Stock was at 07/17/25 04:00 PM ET
What is the market capitalization of Blueprint Medicines Corporation - Common Stock?
The market capitalization of Blueprint Medicines Corporation - Common Stock is 8.22B
How many shares of Blueprint Medicines Corporation - Common Stock are outstanding?
Blueprint Medicines Corporation - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap